# Panacea Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/panacea-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Gaithersburg, US
- Website: www.panaceapharma.com
- Total disclosed funding: $12M
- Latest round: Series C (Dec 31, 2005)
- Investors on record: 5

## About

Established in 1999, Panacea Pharmaceuticals, Inc. is based in Maryland, US and operates as a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic and diagnostic products for cancer and diseases of the central nervous system.

## Funding rounds

- Series C, Dec 31, 2005, $8.9M — SBI Holdings, Mizuho Capital, Kyokuto Securities, Nomura Research and Advisory
- Series B, May 14, 2002, $3M — MedImmune Ventures

## Investors

- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series B
- SBI Holdings — Series C
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series C
- Kyokuto Securities — Series C
- Nomura Research and Advisory (https://capitalatlas.ai/funds/nomura-research-and-advisory) — Series C